These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 37166463)

  • 1. Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications.
    Rani R; Raina N; Sharma A; Kumar P; Tulli HS; Gupta M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2287-2310. PubMed ID: 37166463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
    Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
    Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
    Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
    Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of nanoparticle technology in rheumatoid arthritis treatment.
    Dolati S; Sadreddini S; Rostamzadeh D; Ahmadi M; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2016 May; 80():30-41. PubMed ID: 27133037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.
    Nautiyal G; Sharma SK; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2024; 18(4):433-456. PubMed ID: 37904559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising role of polymeric nanoparticles in the treatment of rheumatoid arthritis.
    Siddique R; Mehmood MH; Haris M; Saleem A; Chaudhry Z
    Inflammopharmacology; 2022 Aug; 30(4):1207-1218. PubMed ID: 35524837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis.
    Zhang Y; Gao Z; Chao S; Lu W; Zhang P
    Drug Deliv; 2022 Dec; 29(1):1934-1950. PubMed ID: 35757855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging the gap in rheumatoid arthritis treatment with hyaluronic acid-based drug delivery approaches.
    Priya S; Daryani J; Desai VM; Singhvi G
    Int J Biol Macromol; 2024 Jun; 271(Pt 1):132586. PubMed ID: 38795889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD34
    Colombo F; Durigutto P; De Maso L; Biffi S; Belmonte B; Tripodo C; Oliva R; Bardini P; Marini GM; Terreno E; Pozzato G; Rampazzo E; Bertrand J; Feuerstein B; Javurek J; Havrankova J; Pitzalis C; Nuñez L; Meroni P; Tedesco F; Sblattero D; Macor P
    J Autoimmun; 2019 Sep; 103():102288. PubMed ID: 31213399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nanometer preparation of traditional Chinese medicine for rheumatoid arthritis].
    Wang HM; Wang M
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):3908-3916. PubMed ID: 31872724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in nanocarrier-based drug delivery systems in treatment of rheumatoid arthritis].
    Liang X; Li YL; Bai HT; Zhang QY; Xiao Z; Sun X; Wen WL; Zhang WY; Yang J; Wang R
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4874-4883. PubMed ID: 37802829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
    Han Y; Huang S
    J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis.
    Singh R; Jadhav K; Vaghasiya K; Ray E; Shukla R; Verma RK
    Curr Pharm Des; 2023; 29(13):984-1001. PubMed ID: 37038685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Nanocarriers in the Management of Rheumatoid Arthritis.
    Mittal V; Sharma A; Sharma D
    Curr Rheumatol Rev; 2024 Jul; ():. PubMed ID: 39082179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.
    Ren S; Xu Y; Dong X; Mu Q; Chen X; Yu Y; Su G
    J Nanobiotechnology; 2024 Jul; 22(1):431. PubMed ID: 39034407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology for Targeted Drug Delivery to Treat Osteoporosis.
    Kaur M; Nagpal M; Aggarwal G
    Curr Drug Targets; 2023; 24(1):2-12. PubMed ID: 36200208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine targeted anti-inflammatory therapy to deal with the 'crux' of rheumatoid arthritis.
    An M; Zhang J; Zhang X; Zhao Y; Liu Y
    J Drug Target; 2024 Apr; 32(4):381-392. PubMed ID: 38321981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.
    Liu L; Hu F; Wang H; Wu X; Eltahan AS; Stanford S; Bottini N; Xiao H; Bottini M; Guo W; Liang XJ
    ACS Nano; 2019 May; 13(5):5036-5048. PubMed ID: 30978282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer nanotherapeutics: A versatile platform for effective rheumatoid arthritis therapy.
    Nooreen R; Nene S; Jain H; Prasannanjaneyulu V; Chitlangya P; Otavi S; Khatri DK; Raghuvanshi RS; Singh SB; Srivastava S
    J Control Release; 2022 Aug; 348():397-419. PubMed ID: 35660632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Move to Nano-Arthrology: Targeted Stimuli-Responsive Nanomedicines Combat Adaptive Treatment Tolerance (ATT) of Rheumatoid Arthritis.
    Liu L; Guo W; Liang XJ
    Biotechnol J; 2019 Jan; 14(1):e1800024. PubMed ID: 30221835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.